Associations of gut microbiome profiles with efficacy and toxicity in CD19-targeted chimeric antigen receptor (CAR) T cell treatment

被引:0
|
作者
Schubert, M. -L [1 ]
Blumenberg, V. [2 ]
Zamir, E. [3 ]
Schmidt, S. [3 ]
Rohrbach, R. [3 ]
Waldhoff, P. [1 ]
Bozic, D. [1 ]
von Bergwelt, M. [2 ]
Mueller-Tidow, C. [1 ]
Dreger, P. [1 ]
Poeck, H. [4 ]
Schmitt, M. [1 ]
Subklewe, M. [2 ]
Stein-Thoeringer, C. [1 ,3 ]
机构
[1] Univ Klinikum Heidelberg, Heidelberg, Germany
[2] Klinikum Ludwig Maximilians Univ LMU Munchen, Munich, Germany
[3] Deutsch Krebsforschungszentrum, Heidelberg, Germany
[4] Univ Klinikum Regensburg, Regensburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V372
引用
收藏
页码:43 / 43
页数:1
相关论文
共 50 条
  • [1] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kline, Kathryn
    Luetkens, Tim
    Koka, Rima
    Kallen, Michael E.
    Chen, Wengen
    Ahmad, Haroon
    Omili, Destiny
    Iraguha, Thierry
    Gebru, Etse
    Fan, Xiaoxuan
    Miller, Alexis
    Dishanthan, Nishanthini
    Baker, Jillian M.
    Dietze, Kenneth A.
    Hankey, Kim G.
    Yared, Jean A.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Dahiya, Saurabh
    Atanackovic, Djordje
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (03)
  • [2] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kathryn Kline
    Tim Luetkens
    Rima Koka
    Michael E. Kallen
    Wengen Chen
    Haroon Ahmad
    Destiny Omili
    Thierry Iraguha
    Etse Gebru
    Xiaoxuan Fan
    Alexis Miller
    Nishanthini Dishanthan
    Jillian M. Baker
    Kenneth A. Dietze
    Kim G. Hankey
    Jean A. Yared
    Nancy M. Hardy
    Aaron P. Rapoport
    Saurabh Dahiya
    Djordje Atanackovic
    Cancer Immunology, Immunotherapy, 73
  • [3] Efficacy of humanized CD19-targeted chimeric antigen receptor (CAR)-modified T cells in children with relapsed ALL
    Maude, Shannon L.
    Barrett, David Maxwell
    Rheingold, Susan R.
    Aplenc, Richard
    Teachey, David T.
    Callahan, Colleen
    Shaw, Pamela A.
    Brogdon, Jennifer
    Young, Regina
    Scholler, John
    Marcucci, Katherine
    Kulikovskaya, Irina
    Nazimuddin, Farzana
    Zheng, Zhaohui
    Levine, Bruce
    Porter, David L.
    Lacey, Simon F.
    Melenhorst, Jan Joseph
    June, Carl H.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Generation of CD19-Targeted Chimeric Antigen Receptor T Cells
    Kiani, Jafar
    Naderi, Mahmood
    Torabi-Rahvar, Monireh
    Ranjbar, Azam
    Aghayan, Hamid-Reza
    Janzamin, Ehsan
    Ahmadbeigi, Naser
    ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (01) : 7 - 10
  • [5] Efficacy of Retreatment with Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children with Relapsed ALL
    Maude, S.
    Barrett, D.
    Rheingold, S.
    Aplenc, R.
    Teachey, D.
    Callahan, C.
    Shaw, P.
    Brogdon, J.
    Young, R.
    Scholler, J.
    Marcucci, K.
    Levine, B.
    Porter, D.
    Lacey, S.
    Melenhorst, J.
    June, C.
    Grupp, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S37 - S37
  • [6] Fungal Infections Associated with CD19-Targeted Chimeric Antigen Receptor T Cell Therapy
    Charles Gaulin
    Zoey Harris
    Rich Kodama
    Monika Shah
    Janis Blair
    Yucai Wang
    Yi Lin
    Javier Muñoz
    Current Fungal Infection Reports, 2023, 17 : 87 - 97
  • [7] Fungal Infections Associated with CD19-Targeted Chimeric Antigen Receptor T Cell Therapy
    Gaulin, Charles
    Harris, Zoey
    Kodama, Rich
    Shah, Monika
    Blair, Janis
    Wang, Yucai
    Lin, Yi
    Munoz, Javier
    CURRENT FUNGAL INFECTION REPORTS, 2023, 17 (02) : 87 - 97
  • [8] The impact of the intestinal microbiome on toxicity and efficacy of CD19-specific chimeric antigen receptor (CAR) T cells
    Schubert, M. -L.
    Blumenberg, V.
    Zamir, E.
    Schmidt, S.
    Rohrbach, R.
    Waldhoff, P.
    Bozic, D.
    von Bergwelt, M.
    Mueller-Tidow, C.
    Dreger, P.
    Schmitt, M.
    Subklewe, M.
    Stein-Thoeringer, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 240 - 241
  • [9] Autologous CD19-Targeted Chimeric Antigen Receptor (CAR)T-Cells as the Future of Systemic Lupus Erythematosus Treatment
    Kambayana, Gede
    Rini, Sandra Surya
    CURRENT RHEUMATOLOGY REVIEWS, 2023, 19 (03) : 260 - 269
  • [10] Therapeutic efficacy and infectious complications of CD19-targeted chimeric antigen receptor-modified T cell immunotherapy
    Gao, Zhilin
    Lian, Yu
    Ti, Juanjuan
    Ren, Ruirui
    Ma, Liangming
    ANTI-CANCER DRUGS, 2023, 34 (04) : 551 - 557